ID   ANPRA_HUMAN             Reviewed;        1061 AA.
AC   P16066; B0ZBF0; Q5SR08; Q6P4Q3;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=Atrial natriuretic peptide receptor 1;
DE            EC=4.6.1.2;
DE   AltName: Full=Atrial natriuretic peptide receptor type A;
DE            Short=ANP-A;
DE            Short=ANPR-A;
DE            Short=NPR-A;
DE   AltName: Full=Guanylate cyclase A;
DE            Short=GC-A;
DE   Flags: Precursor;
GN   Name=NPR1; Synonyms=ANPRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=2569967;
RA   Lowe D.G., Chang M.S., Hellmiss R., Chen E., Singh S., Garbers D.L.,
RA   Goeddel D.V.;
RT   "Human atrial natriuretic peptide receptor defines a new paradigm for
RT   second messenger signal transduction.";
RL   EMBO J. 8:1377-1384(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=9618281; DOI=10.1006/bbrc.1998.8693;
RA   Takahashi Y., Nakayama T., Soma M., Izumi Y., Kanmatsuse K.;
RT   "Organization of the human natriuretic peptide receptor A gene.";
RL   Biochem. Biophys. Res. Commun. 246:736-739(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Maeda N., Knowles J.W.;
RT   "Identification of functional polymorphisms in noncoding regions of
RT   the human natriuretic peptide receptor A gene.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 634-1048.
RC   TISSUE=Retina;
RX   PubMed=7954658; DOI=10.1007/BF02088585;
RA   Pardhasaradhi K., Kutty R.K., Gentleman S., Krishna G.;
RT   "Expression of mRNA for atrial natriuretic peptide receptor guanylate
RT   cyclase (ANPRA) in human retina.";
RL   Cell. Mol. Neurobiol. 14:1-7(1994).
RN   [9]
RP   LIGAND-BINDING.
RX   PubMed=1660465;
RA   Bennett B.D., Bennett G.L., Vitangcol R.V., Jewett J.R., Burnier J.,
RA   Henzel W., Lowe D.G.;
RT   "Extracellular domain-IgG fusion proteins for three human natriuretic
RT   peptide receptors. Hormone pharmacology and application to solid phase
RT   screening of synthetic peptide antisera.";
RL   J. Biol. Chem. 266:23060-23067(1991).
RN   [10]
RP   FUNCTION.
RX   PubMed=1672777; DOI=10.1126/science.1672777;
RA   Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K.,
RA   Matsuo H., Goeddel D.V.;
RT   "Selective activation of the B natriuretic peptide receptor by C-type
RT   natriuretic peptide (CNP).";
RL   Science 252:120-123(1991).
RN   [11]
RP   PHOSPHORYLATION AT SER-519; SER-529; THR-532; SER-534 AND SER-538.
RX   PubMed=20977274; DOI=10.1021/bi101700e;
RA   Yoder A.R., Stone M.D., Griffin T.J., Potter L.R.;
RT   "Mass spectrometric identification of phosphorylation sites in
RT   guanylyl cyclase A and B.";
RL   Biochemistry 49:10137-10145(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-182; CYS-270; MET-755; GLN-939 AND
RP   LYS-967.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for the atrial natriuretic peptide NPPA/ANP and
CC       the brain natriuretic peptide NPPB/BNP which are potent vasoactive
CC       hormones playing a key role in cardiovascular homeostasis. Has
CC       guanylate cyclase activity upon binding of the ligand.
CC       {ECO:0000269|PubMed:1672777}.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Phosphorylation of the protein kinase-like domain is required
CC       for full activation by ANP. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15357; CAA33417.1; -; mRNA.
DR   EMBL; AB010491; BAA31199.1; -; Genomic_DNA.
DR   EMBL; AF190631; AAF01340.1; -; Genomic_DNA.
DR   EMBL; EU326310; ACA05918.1; -; Genomic_DNA.
DR   EMBL; AL713889; CAI13613.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53284.1; -; Genomic_DNA.
DR   EMBL; BC063304; AAH63304.1; -; mRNA.
DR   EMBL; S72628; AAD14112.1; -; mRNA.
DR   CCDS; CCDS1051.1; -.
DR   PIR; S04459; OYHUAR.
DR   RefSeq; NP_000897.3; NM_000906.3.
DR   UniGene; Hs.490330; -.
DR   ProteinModelPortal; P16066; -.
DR   SMR; P16066; -.
DR   BioGrid; 110941; 5.
DR   DIP; DIP-46246N; -.
DR   IntAct; P16066; 3.
DR   MINT; MINT-1192002; -.
DR   STRING; 9606.ENSP00000357669; -.
DR   BindingDB; P16066; -.
DR   ChEMBL; CHEMBL1988; -.
DR   DrugBank; DB01612; Amyl Nitrite.
DR   DrugBank; DB01613; Erythrityl Tetranitrate.
DR   DrugBank; DB00883; Isosorbide Dinitrate.
DR   DrugBank; DB04899; Nesiritide.
DR   DrugBank; DB00727; Nitroglycerin.
DR   DrugBank; DB00325; Nitroprusside.
DR   DrugBank; DB05034; Ularitide.
DR   GuidetoPHARMACOLOGY; 1747; -.
DR   iPTMnet; P16066; -.
DR   PhosphoSitePlus; P16066; -.
DR   BioMuta; NPR1; -.
DR   DMDM; 113912; -.
DR   EPD; P16066; -.
DR   MaxQB; P16066; -.
DR   PaxDb; P16066; -.
DR   PeptideAtlas; P16066; -.
DR   PRIDE; P16066; -.
DR   DNASU; 4881; -.
DR   Ensembl; ENST00000368680; ENSP00000357669; ENSG00000169418.
DR   GeneID; 4881; -.
DR   KEGG; hsa:4881; -.
DR   UCSC; uc001fcs.5; human.
DR   CTD; 4881; -.
DR   DisGeNET; 4881; -.
DR   GeneCards; NPR1; -.
DR   HGNC; HGNC:7943; NPR1.
DR   HPA; HPA031087; -.
DR   MIM; 108960; gene.
DR   neXtProt; NX_P16066; -.
DR   OpenTargets; ENSG00000169418; -.
DR   PharmGKB; PA31736; -.
DR   eggNOG; KOG1023; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000118959; -.
DR   HOGENOM; HOG000293307; -.
DR   HOVERGEN; HBG051862; -.
DR   InParanoid; P16066; -.
DR   KO; K12323; -.
DR   OMA; QYSELVV; -.
DR   OrthoDB; EOG091G02QS; -.
DR   PhylomeDB; P16066; -.
DR   TreeFam; TF106338; -.
DR   BRENDA; 4.6.1.2; 2681.
DR   Reactome; R-HSA-5578768; Physiological factors.
DR   SignaLink; P16066; -.
DR   SIGNOR; P16066; -.
DR   GeneWiki; NPR1; -.
DR   GenomeRNAi; 4881; -.
DR   PRO; PR:P16066; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000169418; -.
DR   CleanEx; HS_NPR1; -.
DR   ExpressionAtlas; P16066; baseline and differential.
DR   Genevisible; P16066; HS.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0008528; F:G-protein coupled peptide receptor activity; NAS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0042562; F:hormone binding; IPI:UniProtKB.
DR   GO; GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB.
DR   GO; GO:0017046; F:peptide hormone binding; IEA:Ensembl.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0007589; P:body fluid secretion; TAS:UniProtKB.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0042417; P:dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; TAS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; TAS:UniProtKB.
DR   GO; GO:0035810; P:positive regulation of urine volume; TAS:UniProtKB.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; NAS:UniProtKB.
DR   GO; GO:0097746; P:regulation of blood vessel diameter; NAS:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0043114; P:regulation of vascular permeability; TAS:UniProtKB.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001170; ANPR/GUC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00255; NATPEPTIDER.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00458; ANF_RECEPTORS; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   cGMP biosynthesis; Chloride; Complete proteome; Disulfide bond;
KW   Glycoprotein; GTP-binding; Lyase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Vasoactive.
FT   SIGNAL        1     32
FT   CHAIN        33   1061       Atrial natriuretic peptide receptor 1.
FT                                /FTId=PRO_0000012360.
FT   TOPO_DOM     33    473       Extracellular. {ECO:0000255}.
FT   TRANSMEM    474    494       Helical. {ECO:0000255}.
FT   TOPO_DOM    495   1061       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      528    805       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      876   1006       Guanylate cyclase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   BINDING      85     85       Chloride. {ECO:0000250}.
FT   BINDING     117    117       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     118    118       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   MOD_RES     519    519       Phosphoserine.
FT                                {ECO:0000269|PubMed:20977274}.
FT   MOD_RES     529    529       Phosphoserine.
FT                                {ECO:0000269|PubMed:20977274}.
FT   MOD_RES     532    532       Phosphothreonine.
FT                                {ECO:0000269|PubMed:20977274}.
FT   MOD_RES     534    534       Phosphoserine.
FT                                {ECO:0000269|PubMed:20977274}.
FT   MOD_RES     538    538       Phosphoserine.
FT                                {ECO:0000269|PubMed:20977274}.
FT   MOD_RES     542    542       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18910}.
FT   MOD_RES     545    545       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P18910}.
FT   CARBOHYD     34     34       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    379    379       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    386    386       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    427    427       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     92    118       {ECO:0000250}.
FT   DISULFID    196    245       {ECO:0000250}.
FT   DISULFID    455    464       {ECO:0000250}.
FT   VARIANT     182    182       A -> V (in dbSNP:rs56019647).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042214.
FT   VARIANT     270    270       F -> C (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042215.
FT   VARIANT     755    755       V -> M (in dbSNP:rs55837780).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042216.
FT   VARIANT     939    939       R -> Q (in dbSNP:rs35240348).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042217.
FT   VARIANT     967    967       E -> K (in dbSNP:rs35479618).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042218.
FT   CONFLICT    344    344       G -> V (in Ref. 7; AAH63304).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1061 AA;  118919 MW;  E6B5BD0FCA32F70D CRC64;
     MPGPRRPAGS RLRLLLLLLL PPLLLLLRGS HAGNLTVAVV LPLANTSYPW SWARVGPAVE
     LALAQVKARP DLLPGWTVRT VLGSSENALG VCSDTAAPLA AVDLKWEHNP AVFLGPGCVY
     AAAPVGRFTA HWRVPLLTAG APALGFGVKD EYALTTRAGP SYAKLGDFVA ALHRRLGWER
     QALMLYAYRP GDEEHCFFLV EGLFMRVRDR LNITVDHLEF AEDDLSHYTR LLRTMPRKGR
     VIYICSSPDA FRTLMLLALE AGLCGEDYVF FHLDIFGQSL QGGQGPAPRR PWERGDGQDV
     SARQAFQAAK IITYKDPDNP EYLEFLKQLK HLAYEQFNFT MEDGLVNTIP ASFHDGLLLY
     IQAVTETLAH GGTVTDGENI TQRMWNRSFQ GVTGYLKIDS SGDRETDFSL WDMDPENGAF
     RVVLNYNGTS QELVAVSGRK LNWPLGYPPP DIPKCGFDNE DPACNQDHLS TLEVLALVGS
     LSLLGILIVS FFIYRKMQLE KELASELWRV RWEDVEPSSL ERHLRSAGSR LTLSGRGSNY
     GSLLTTEGQF QVFAKTAYYK GNLVAVKRVN RKRIELTRKV LFELKHMRDV QNEHLTRFVG
     ACTDPPNICI LTEYCPRGSL QDILENESIT LDWMFRYSLT NDIVKGMLFL HNGAICSHGN
     LKSSNCVVDG RFVLKITDYG LESFRDLDPE QGHTVYAKKL WTAPELLRMA SPPVRGSQAG
     DVYSFGIILQ EIALRSGVFH VEGLDLSPKE IIERVTRGEQ PPFRPSLALQ SHLEELGLLM
     QRCWAEDPQE RPPFQQIRLT LRKFNRENSS NILDNLLSRM EQYANNLEEL VEERTQAYLE
     EKRKAEALLY QILPHSVAEQ LKRGETVQAE AFDSVTIYFS DIVGFTALSA ESTPMQVVTL
     LNDLYTCFDA VIDNFDVYKV ETIGDAYMVV SGLPVRNGRL HACEVARMAL ALLDAVRSFR
     IRHRPQEQLR LRIGIHTGPV CAGVVGLKMP RYCLFGDTVN TASRMESNGE ALKIHLSSET
     KAVLEEFGGF ELELRGDVEM KGKGKVRTYW LLGERGSSTR G
//
